Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
40.82 USD | -2.79% | -2.13% | -32.42% |
May. 07 | MoonLake Immunotherapeutics Q1 Net Loss Widens | MT |
May. 07 | MoonLake Immunotherapeutics Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.42% | 2.64B | |
+16.73% | 121B | |
+13.09% | 107B | |
-5.74% | 24.82B | |
+1.69% | 22.48B | |
-10.09% | 18.32B | |
-40.52% | 16.33B | |
-14.01% | 15.31B | |
+1.31% | 14.08B | |
+24.15% | 11.74B |
- Stock Market
- Equities
- MLTX Stock
- News MoonLake Immunotherapeutics
- Guggenheim Adjusts Price Target on MoonLake Immunotherapeutics to $65 From $51, Maintains Buy Rating